tiprankstipranks
Trending News
More News >
Chiome Bioscience Inc. (JP:4583)
:4583
Japanese Market
Advertisement

Chiome Bioscience Inc. (4583) Stock Statistics & Valuation Metrics

Compare
1 Followers

Total Valuation

Chiome Bioscience Inc. has a market cap or net worth of ¥10.07B. The enterprise value is ¥8.53B.
Market Cap¥10.07B
Enterprise Value¥8.53B

Share Statistics

Chiome Bioscience Inc. has 68,053,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,053,800
Owned by Insiders
Owned by Institutions

Financial Efficiency

Chiome Bioscience Inc.’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -45.82%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.41
Return on Invested Capital (ROIC)-45.82%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee16.61M
Profits Per Employee-21.72M
Employee Count47
Asset Turnover0.32
Inventory Turnover7.54

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio5.72
Price to Fair Value8.15
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-1.31

Income Statement

In the last 12 months, Chiome Bioscience Inc. had revenue of 780.81M and earned -1.02B in profits. Earnings per share was -17.54.
Revenue780.81M
Gross Profit432.85M
Operating Income-1.03B
Pretax Income-1.02B
Net Income-1.02B
EBITDA-1.01B
Earnings Per Share (EPS)-17.54

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Chiome Bioscience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.94
52-Week Price Change14.96%
50-Day Moving Average147.28
200-Day Moving Average163.64
Relative Strength Index (RSI)46.21
Average Volume (3m)1.40M

Important Dates

Chiome Bioscience Inc. upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Chiome Bioscience Inc. as a current ratio of 4.74, with Debt / Equity ratio of 15.98%
Current Ratio4.74
Quick Ratio4.64
Debt to Market Cap0.02
Net Debt to EBITDA1.76
Interest Coverage Ratio-359.81

Taxes

In the past 12 months, Chiome Bioscience Inc. has paid 3.24M in taxes.
Income Tax3.24M
Effective Tax Rate>-0.01

Enterprise Valuation

Chiome Bioscience Inc. EV to EBITDA ratio is -13.69, with an EV/FCF ratio of -13.87.
EV to Sales17.77
EV to EBITDA-13.69
EV to Free Cash Flow-13.87
EV to Operating Cash Flow-13.87

Balance Sheet

Chiome Bioscience Inc. has ¥2.06B in cash and marketable securities with ¥281.50M in debt, giving a net cash position of -¥1.78B billion.
Cash & Marketable Securities¥2.06B
Total Debt¥281.50M
Net Cash-¥1.78B
Net Cash Per Share-¥26.18
Tangible Book Value Per Share¥32.99

Margins

Gross margin is 57.79%, with operating margin of -132.03%, and net profit margin of -130.73%.
Gross Margin57.79%
Operating Margin-132.03%
Pretax Margin-130.32%
Net Profit Margin-130.73%
EBITDA Margin-129.80%
EBIT Margin-132.03%

Analyst Forecast

The average price target for Chiome Bioscience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast14.41%
EPS Growth Forecast27.42%

Scores

Smart ScoreN/A
AI Score48.2
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis